M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic and plastic surgery in Europe.
Undervalued with excellent balance sheet.
Share Price & News
How has M1 Kliniken's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: M12 has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: M12 underperformed the German Healthcare industry which returned -2.6% over the past year.
Return vs Market: M12 underperformed the German Market which returned 3.4% over the past year.
Price Volatility Vs. Market
How volatile is M1 Kliniken's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StWe Like These Underlying Trends At M1 Kliniken (ETR:M12)
4 weeks ago | Simply Wall StThe M1 Kliniken (ETR:M12) Share Price Is Down 23% So Some Shareholders Are Getting Worried
3 months ago | Simply Wall StWhy We Like M1 Kliniken AG’s (ETR:M12) 12% Return On Capital Employed
Is M1 Kliniken undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: M12 (€10.6) is trading below our estimate of fair value (€19.01)
Significantly Below Fair Value: M12 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: M12 is good value based on its PE Ratio (19.1x) compared to the DE Healthcare industry average (25.8x).
PE vs Market: M12 is good value based on its PE Ratio (19.1x) compared to the German market (20.9x).
Price to Earnings Growth Ratio
PEG Ratio: M12 is good value based on its PEG Ratio (1x)
Price to Book Ratio
PB vs Industry: M12 is overvalued based on its PB Ratio (2.7x) compared to the DE Healthcare industry average (1.4x).
How is M1 Kliniken forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: M12's forecast earnings growth (20% per year) is above the savings rate (0.2%).
Earnings vs Market: M12's earnings (20% per year) are forecast to grow slower than the German market (22.4% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: M12's revenue (25.5% per year) is forecast to grow faster than the German market (6% per year).
High Growth Revenue: M12's revenue (25.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: M12's Return on Equity is forecast to be low in 3 years time (9.1%).
How has M1 Kliniken performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: M12 has a high level of non-cash earnings.
Growing Profit Margin: M12's current net profit margins (12.6%) are higher than last year (10.1%).
Past Earnings Growth Analysis
Earnings Trend: M12's earnings have grown by 4.4% per year over the past 5 years.
Accelerating Growth: M12's earnings growth over the past year (47.1%) exceeds its 5-year average (4.4% per year).
Earnings vs Industry: M12 earnings growth over the past year (47.1%) exceeded the Healthcare industry 9.7%.
Return on Equity
High ROE: M12's Return on Equity (14.3%) is considered low.
How is M1 Kliniken's financial position?
Financial Position Analysis
Short Term Liabilities: M12's short term assets (€59.3M) exceed its short term liabilities (€14.4M).
Long Term Liabilities: M12's short term assets (€59.3M) exceed its long term liabilities (€10.2M).
Debt to Equity History and Analysis
Debt Level: M12's debt to equity ratio (0.1%) is considered satisfactory.
Reducing Debt: M12's debt to equity ratio has reduced from 7.9% to 0.1% over the past 5 years.
Debt Coverage: M12's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: M12 earns more interest than it pays, so coverage of interest payments is not a concern.
What is M1 Kliniken current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: M12's dividend (2.83%) is higher than the bottom 25% of dividend payers in the German market (1.25%).
High Dividend: M12's dividend (2.83%) is low compared to the top 25% of dividend payers in the German market (3.78%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, M12 has been paying a dividend for less than 10 years.
Growing Dividend: M12 has only been paying a dividend for 4 years, and since then payments have not increased.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (54%), M12's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: M12's dividends in 3 years are forecast to be well covered by earnings (48.4% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Mr. Patrick Brenske has been Chief Executive Officer of MPH Health Care AG (formerly known as MPH Mittelständische Pharma Holding AG) since January 23, 2009 and has been its Member of Management Board sinc ...
|Chairman of Supervisory Board||3.08yrs||no data||no data|
|Member of Supervisory Board||5.08yrs||no data||no data|
|Deputy Chairman of Supervisory Board||3.08yrs||no data||no data|
Experienced Board: M12's board of directors are considered experienced (3.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
M1 Kliniken AG's company bio, employee growth, exchange listings and data sources
- Name: M1 Kliniken AG
- Ticker: M12
- Exchange: XTRA
- Founded: 2007
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: €185.500m
- Shares outstanding: 17.50m
- Website: https://www.m1-kliniken.de
Number of Employees
- M1 Kliniken AG
- Grünauer Strasse 5
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|M12||DB (Deutsche Boerse AG)||Yes||Bearer Shares||DE||EUR||Sep 2015|
|M12||XTRA (XETRA Trading Platform)||Yes||Bearer Shares||DE||EUR||Sep 2015|
M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic and plastic surgery in Europe. It develops and markets pharmaceutical, medical, and medical technology products for aesthetic medicine, plastic surgery, and cosmetic dermatology. The company also engages in the acquisition, development, operation, and sale of real estate, primarily in the health care sector. In addition, it offers its products to private customers, doctors, pharmacies, and wholesalers under the M1 Select and M1 Aesthetics brands. As of July 12, 2019, it operated a network of 25 outpatient specialist centers for beauty treatments; and a specialist surgical clinic with 6 operating theatres and 35 beds under the M1 Med Beauty, M1 Laser, and M1 Dental brand names. M1 Kliniken AG was founded in 2007 and is based in Berlin, Germany.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/07/15 20:58|
|End of Day Share Price||2020/07/15 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.